tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

OCUL Stock Latest News

Ocular Therapeutix price target raised to $15 from $14 at H.C. Wainwright
The FlyOcular Therapeutix price target raised to $15 from $14 at H.C. Wainwright
7d ago
OCUL
Ocular Therapeutix Reports Q3 2024 Financial Results
PremiumCompany Announcements
Ocular Therapeutix Reports Q3 2024 Financial Results
7d ago
OCUL
Ocular Therapeutix reports Q3 EPS (22c), consensus (21c)
PremiumThe Fly
Ocular Therapeutix reports Q3 EPS (22c), consensus (21c)
8d ago
OCUL
Ocular Therapeutix appoints Saroj as Chief Business Officer
PremiumThe Fly
Ocular Therapeutix appoints Saroj as Chief Business Officer
10d ago
OCUL
OCUL Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
OCUL Upcoming Earnings Report: What to Expect?
20d ago
OCUL
Disney initiated, Cisco upgraded: Wall Street’s top analyst calls
PremiumThe FlyDisney initiated, Cisco upgraded: Wall Street’s top analyst calls
1M ago
EL
AAP
Ocular Therapeutix initiated with an Outperform at Scotiabank
Premium
The Fly
Ocular Therapeutix initiated with an Outperform at Scotiabank
1M ago
OCUL
Ocular Therapeutix management to meet with Piper Sandler
Premium
The Fly
Ocular Therapeutix management to meet with Piper Sandler
1M ago
OCUL
Ocular announces accelerated timelines for SOL-1 registrational trial
PremiumThe Fly
Ocular announces accelerated timelines for SOL-1 registrational trial
1M ago
OCUL
Ocular Therapeutix Expands Stock Incentive Plan for Employees
PremiumCompany Announcements
Ocular Therapeutix Expands Stock Incentive Plan for Employees
1M ago
8K
OCUL
JMP Securities healthcare analysts hold an analyst/industry conference call
PremiumThe Fly
JMP Securities healthcare analysts hold an analyst/industry conference call
2M ago
OPT
ABBV
Ocular Therapeutix Appoints Donald Notman as COO
PremiumCompany Announcements
Ocular Therapeutix Appoints Donald Notman as COO
3M ago
8K
OCUL
Ocular Therapeutix reports inducement grants under Nasdaq listing rule
PremiumThe FlyOcular Therapeutix reports inducement grants under Nasdaq listing rule
3M ago
OCUL
Ocular Therapeutix price target lowered to $17 from $18 at Baird
Premium
The Fly
Ocular Therapeutix price target lowered to $17 from $18 at Baird
4M ago
OCUL
Ocular Therapeutix announces FDA feedback on Phase 3 SOL-R trial
Premium
The Fly
Ocular Therapeutix announces FDA feedback on Phase 3 SOL-R trial
4M ago
OCUL
Ocular Therapeutix sees cash runway into 2028
PremiumThe Fly
Ocular Therapeutix sees cash runway into 2028
4M ago
OCUL
Ocular Therapeutix reports Q2 EPS (26c), consensus (22c)
PremiumThe Fly
Ocular Therapeutix reports Q2 EPS (26c), consensus (22c)
4M ago
OCUL
OCUL Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
OCUL Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4M ago
OCUL
Ocular Therapeutix announces first patients enrolled in Phase 3 SOL-R study
PremiumThe Fly
Ocular Therapeutix announces first patients enrolled in Phase 3 SOL-R study
4M ago
OCUL
Ocular Therapeutix (NASDAQ:OCUL): Promising Treatment Fuels Growth Potential
PremiumMarket NewsOcular Therapeutix (NASDAQ:OCUL): Promising Treatment Fuels Growth Potential
5M ago
OCUL
Ocular Therapeutix upgraded to Buy at TD Cowen with SOL-1 trial ‘going great’
Premium
The Fly
Ocular Therapeutix upgraded to Buy at TD Cowen with SOL-1 trial ‘going great’
5M ago
OCUL
Ocular Therapeutix upgraded to Buy from Hold at TD Cowen
Premium
The Fly
Ocular Therapeutix upgraded to Buy from Hold at TD Cowen
5M ago
OCUL

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >